{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:19:23Z","timestamp":1790489963759,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cgh.2014.12.017","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:40:48Z","timestamp":1419381648000},"page":"1532-1539.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B"],"prefix":"10.1016","volume":"13","author":[{"given":"Patrick","family":"Marcellin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Martinot-Peignoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Asselah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Batrla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethelm","family":"Messinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fan","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2014.12.017_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.017_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2014.12.017_bib3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2013.03.002","article-title":"Focus: quantitative HBsAg measurement as a new surrogate marker for assessment of hepatic fibrosis in HBeAg+ chronic hepatitis B","volume":"58","author":"Shouval","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.017_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2008.01802.x","article-title":"Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B","volume":"29","author":"Marcellin","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2014.12.017_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3851\/IMP1570","article-title":"Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies","volume":"15","author":"Poynard","year":"2010","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.cgh.2014.12.017_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2036.2010.04547.x","article-title":"Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers","volume":"33","author":"Castera","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2014.12.017_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-11-91","article-title":"Non-invasive markers for hepatic fibrosis","volume":"11","author":"Baranova","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2014.12.017_bib8","doi-asserted-by":"crossref","first-page":"e43087","DOI":"10.1371\/journal.pone.0043087","article-title":"High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B","volume":"7","author":"Seto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2014.12.017_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2013.01.028","article-title":"Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-na\u00efve, e antigen-positive patients","volume":"58","author":"Martinot-Peignoux","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.017_bib10","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2014.12.017_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/hep.24555","article-title":"Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B antigen seroconversion rates in hepatitis B virus genotypes B or C","volume":"54","author":"Liaw","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.017_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2014.12.017_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jhep.2014.03.006","article-title":"Improving performance of liver biopsy in fibrosis assessment","volume":"61","author":"Asselah","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.017_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-011-9280-0","article-title":"Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients","volume":"7","author":"Piratvisuth","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2014.12.017_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia","volume":"52","author":"Nguyen","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2014.12.017_bib16","doi-asserted-by":"crossref","first-page":"e87344","DOI":"10.1371\/journal.pone.0087344","article-title":"Enhanced HBsAg synthesis correlates with increased severity of fibrosis in chronic hepatitis B patients","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514018291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356514018291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:17:35Z","timestamp":1761542255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356514018291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1542356514018291"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2014.12.017","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2014.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}